Yadav Madhu, Akhter Yusuf
Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow, 226025 Uttar Pradesh India.
3 Biotech. 2025 Sep;15(9):288. doi: 10.1007/s13205-025-04453-9. Epub 2025 Aug 8.
Type 2 diabetes mellitus (T2DM) is a chronic and debilitating condition characterized by both insufficient production of insulin and insulin resistance, leading to poor blood sugar control. India ranks second globally in diabetes prevalence, with approximately 77 million individuals currently affected by the disease. Although extensive research has been conducted, the molecular mechanisms of T2DM remain inadequately understood, which continues to pose challenges in the development of effective therapeutic strategies. In this study, we analyzed the GSE25724 microarray dataset and identified 2048 differentially expressed genes (DEGs) associated with T2DM. Among these, key hub genes include and , which were identified through Cytoscape as central regulators, implicating inflammatory and immune pathways in T2DM progression. Using NetworkAnalyst, identified key transcription factors ( and ) and microRNA (hsa-miR-16-5p, hsa-miR-26b-5p, hsa-miR-93-5p, hsa-miR-192-5p, and hsa-miR-155-5p) that regulates important genes involved in T2DM, highlighting the complex gene regulation behind the disease. Genes such as , and from key signalling pathways, as well as , and identified through gene-disease association databases, have strong links to type 2 diabetes. These genes are believed to play potential roles in the development and progression of T2DM by participating in biological pathways relevant to the disease. Among the hub genes, , and exhibited strong diagnostic accuracy for T2DM, with each achieving ROC curve and AUC values greater than 0.90. This indicates exceptional sensitivity and specificity in distinguishing T2DM from non-diabetic controls. Overall, our findings shed light on the molecular mechanism of T2DM and identify novel biomarkers and therapeutic targets that may support future precision medicine strategies to enhance diagnosis and treatment outcomes.
The online version contains supplementary material available at 10.1007/s13205-025-04453-9.
2型糖尿病(T2DM)是一种慢性衰弱性疾病,其特征是胰岛素分泌不足和胰岛素抵抗,导致血糖控制不佳。印度的糖尿病患病率在全球排名第二,目前约有7700万人受该疾病影响。尽管已经进行了广泛的研究,但T2DM的分子机制仍未得到充分理解,这在有效治疗策略的开发中仍然构成挑战。在本研究中,我们分析了GSE25724基因芯片数据集,并鉴定出2048个与T2DM相关的差异表达基因(DEG)。其中,关键枢纽基因包括[具体基因1]和[具体基因2],通过Cytoscape鉴定为中心调节因子,提示炎症和免疫途径在T2DM进展中起作用。使用NetworkAnalyst,鉴定出调节T2DM相关重要基因的关键转录因子([具体转录因子1]和[具体转录因子2])和微小RNA(hsa-miR-16-5p、hsa-miR-26b-5p、hsa-miR-93-5p、hsa-miR-192-5p和hsa-miR-155-5p),突出了该疾病背后复杂的基因调控。关键信号通路中的[具体基因3]、[具体基因4]和[具体基因5]等基因以及通过基因-疾病关联数据库鉴定出的[具体基因6]、[具体基因7]和[具体基因8]与2型糖尿病有很强的联系。这些基因被认为通过参与与该疾病相关的生物学途径在T2DM的发生和发展中发挥潜在作用。在枢纽基因中,[具体基因9]、[具体基因10]和[具体基因11]对T2DM表现出很强的诊断准确性,每个基因实现的ROC曲线和AUC值均大于0.90。这表明在区分T2DM与非糖尿病对照方面具有卓越的敏感性和特异性。总体而言,我们的研究结果揭示了T2DM的分子机制,并鉴定出可能支持未来精准医学策略以提高诊断和治疗效果的新型生物标志物和治疗靶点。
在线版本包含可在10.1007/s13205-025-04453-9获取的补充材料。